Key facts
- Notable investors include Mana Ventures, Gaingels, 2468 Ventures, Menon VC, Tomorrow Ventures — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Hologen
- ·The full record, as it builds
Funding rounds
No funding rounds for Hologen are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hologen
Developer of multi-modal generative AI models designed to improve the understanding, design, evaluation, and delivery of treatments for neurological and other complex health conditions. The company offers disease-specific large-scale biological models, anatomically targeted therapeutic platforms, and real-world clinical data integration, enabling pharmaceutical companies and healthcare providers to develop personalized interventions and enhance treatment success in late-stage drug development.
- Sector
- Healthcare
- HQ
- Saint Peter Port, United Kingdom
- Founded
- 2023
- Employees
- 2
- Website
- hologen.ai/
- Ownership
- Privately Held (backing)
Hologen doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hologen shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hologen in its N-PORT filings yet. We sweep new filings monthly.